Publications

2009

  1. GIANGREGORIO L† AND COOK RJ. Hypothesis testing in clinical and basic science research. (4 pages, 2010, Transfusion - in press).

  2. TOLUSSO D† AND COOK RJ. Robust estimation of state occupancy probabilities for interval-censored multistate data: An application involving spondylitis in psoriatic arthritis. Communications in Statistics: Theory and Methods, 2009, 38(18), 3307-3325).

  3. TOLUSSO D† AND COOK RJ. Local likelihood for right and interval censored recurrent event data. (Advances and Applications in Statistical Sciences, 2010, 1, 343-369.

  4. SUTRADHAR R† AND COOK RJ. A bivariate mover-stayer model for interval-censored recurrent event data: Application to joint damage in rheumatology. Communications in Statistics: Theory and Methods, 2009, 18, 3389-3405.

  5. CHEN B†, YI GY AND COOK RJ. Analysis of interval-censored disease progression data via multistate models under a nonignorable inspection process. Statistics in Medicine, 2010, 29(11), 1175-1189.

  6. CHEN B†, YI GY AND COOK RJ. Weighted generalized estimating functions for incomplete longitudinal response and covariate data, that are missing at random. Journal of the American Statistical Association, 2010, 105(489), 336-353.

  7. WARKENTIN TE AND COOK RJ. Impact of laboratory testing for heparin-induced antibodies: using Bayes’ rule to prevent overdiagnosis. Journal of Laboratory Medicine, 2010, published on-line July 21, 2010.

  8. CHANDRAN V, GOTTLIEB A, COOK RJ, CALLIS K, GARG A, HELLIWELL P, KAVANAUGH A, KREUGER J, LANGLEY R, LYNDE C, MCHUGH N, MEASE P, OLIVIERI I, RAHMAN P, ROSEN C, SALVARANI C, THACI D, TOLOZA S, WONG M, ZHOU Q, GLADMAN DD. International Multi-centre Psoriasis and Psoriatic Arthritis Reliability Trial (GRAPPA-IMPART): Assessment of Skin, Joints, Nails and Dactylitis. Arthritis Care and Research, 2009, 61(9), 12345-1242..

  9. WONG RK, SAGAR SM, CHEN B, YI GY AND COOK RJ. Phase II randomized controlled trial of acupuncturelike transcutaneous electrical nerve stimulation to prevent radiation-induced erostomia in head and neck cancer patients. Journal of the Society for Integrative Oncology, 2010, 8(2), 35-42.

  10. MAJOR, PP, COOK RJ, LIPTON A, SMITH MR, TERPOS E, COLEMAN RE. Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer, 2009, 9, 1–12.

  11. ZENG L, COOK RJ AND WARKENTIN TE. Regression analysis with a misclassified covariate from a current status observation scheme. Biometrics, 2009, 66(2), 415-425.

  12. COOK RJ AND HEDDLE NM. Measuring and reporting the effect of an intervention: absolute measures. Transfusion, 2009, 49, 2022-2023.

  13. CHEN B†, YI GY AND COOK RJ. Likelihood analysis of joint marginal and conditional models for longitudinal categorical data. Canadian Journal of Statistics, 2009, 37(2), 182–205.

  14. COOK RJ, BERGERON PJ†, BOHER JM†, LIU Y†. Two-stage trial design for recurrent events. Statistics in Medicine, 2009, 28, 2617–2638.

  15. COOK RJ AND TOLUSSO D†. Second order estimating equations for the analysis of clustered current status data. Biostatistics, 2009, 10(3), 1–17.

  16. COOK RJ AND HEDDLE NM. Measuring and reporting the effect of an intervention: relative measures. Transfusion, 2009, 49(1), 9–12.

  17. HEDDLE NM, COOK RJ, TINMOUTH A, KOUROUKIS CT, HERVIG T, KLAPPER E, BRANDWEIN J, SZCZEPIORKOWSKI ZM, AUBUCHON JP, BARTY R, LEE K-A FOR THE STOP STUDY INVESTIGATORS OF THE BEST COLLABORATIVE. A randomized controlled trial comparing standard and low-dose strategies for transfusion of platelets (SToP) for patients with thrombocytopenia. Blood, 2009, 113, 1564–1573.

  18. WARKENTIN TE, SHEPPARD J, MOORE JC, COOK RJ, AND KELTON JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood, 2009, 113, 4963–4969.

  19. HAYWARD CPM, MOFFAT KA, PAI P, LIU J, SEECHARAN J, MCKAY H, WEBERT KE, COOK RJ, HEDDLE NM. Evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thrombosis and Haemostasis, 2009, 100(1), 134–145.

  20. COOK RJ, LAWLESS JF, LAKHAL-CHAIEB L† AND LEE K-A. Robust estimation of mean functions and treatment effects for recurrent events under event-dependent censoring and termination: Application to skeletal complications in cancer metastatic to bone Journal of the American Statistical Association, 2009, 104, 60-75.

  21. CHEN EB† AND COOK RJ. The analysis of multivariate recurrent events with partially missing event types. Lifetime Data Analysis, 2009, 15, 41-58.

  22. STOLEE P, POSS J, COOK RJ, BYRNE K AND HIRDES JP. Risk factors for hip fracture in older home care clients. Journal of the American Geriatric Society, 2009, 64(3), 403-410.

2008

  1. COOK RJ, ZENG L† AND LEE K-A. A multistate model for bivariate interval censored failure time data. Biometrics, 2008, 64, 1100-1109.

  2. SUTRADHAR R† AND COOK RJ. Analysis of interval-censored data from clustered multistate processes: Application to joint damage in psoriatic arthritis. Journal of the Royal Statistical Society - Series C, 2008, 57, 553-566.

  3. ZENG L AND COOK RJ. A multivariate random effect model for clustered interval-censored time to joint damage in psoriatic arthritis. Journal of Biostatistics, 2008, 2, 193-215.

  4. HE X, TONG X, SUN J , COOK RJ. Regression analysis of multivariate panel count data. Biostatistics, 2008, 9, 234-248.

  5. LIPTON A, COOK RJ , SAAD F, MAJOR P, GARNERO P, TERPOS E, BROWN J, COLEMAN RE. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer, 2008, 113:193-201.

  6. HIRSH V, MAJOR PP, LIPTON A, COOK RJ, LANGER CJ, SMITH MR, BROWN JE, COLEMAN RE. Zole-dronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. Journal of Thoracic Oncology, 2008, 3, 228-236.

  7. COLEMAN RE, BROWN J , TERPOS E, LIPTON A, SMITH MR, COOK RJ , MAJOR PP. Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. Cancer Treatment Reviews, 2008, 34, 629-639.

  8. COOK RJ, WHITE BJ G†, YI Y, LEE K-A AND WARKENTIN TE. Analysis of a non-susceptible fraction with current status data. Statistics in Medicine, 2008, 27. 2715-2730.

2007

  1. COOK RJ, LEE K-A AND LI H† . Non-inferiority design with recurrent events. Statistics in Medicine, 2007, 26: 4563-4577

  2. ZENG L† AND COOK RJ. Transition models for multivariate longitudinal binary data. Journal of the American Statistical Association, 2007, 102: 211-223.

  3. GIANGREGORIO L† AND COOK RJ. Non-inferiority trial design. Transfusion, 2007, 47, 2336-2337.

  4. LIPTON A, COOK RJ, COLEMAN RE, SMITH MR, MAJOR P, TERPOS E AND BERENSON J R. Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma. Clinical Lymphoma and Myeloma 2007, 7(5) : 346-353.

  5. LIPTON A, COOK RJ , MAJOR P, SMITH MR, COLEMAN RE. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. The Oncologist, 2007, 12: 1035-1043.

  6. SMITH MR, COOK RJ, COLEMAN R, BROWN J, LIPTON A, MAJOR P, HEI YJ, SAAD F. Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer. Journal of Urology, 2007 70, 315-319.

  7. WEBERT KE, COOK RJ, COUBAN S, CARRUTHERS J, BLAJCHMAN MA, SUTTON DM, LIPTON JH, BRANDWEIN J , HEDDLE NM. A multicenter pilot randomized controlled trial of the feasibility of an intensive red cell transfusion policy for patients treated with induction chemotherapy for acute leukemia or stem cell transplant. Transfusion, 2007, 48: 81-91.

  8. D'SILVA L, COOK RJ, ALLEN CJ, HARGREAVE FE, PARAMSWARAN K. Changing types of bronchitis during successive exacerbations of airway disease. Respiratory Medicine, 2007, 101: 2217-2220.

  9. GLADMAN DD, INMAN RD, COOK RJ, VANDERHEIJDE D, LANDEWE R, BRAUN J, DAVIS JC, MEASE J, BRANDT J, BURGOS VARGAS R, CHANDRAN V, HELLIWELL P, KAVANAUGH A, O'SHEA FD, KHAN MA, PIPITONE N, RAHMAN P, REVEILLE JD, STONE M, TAYLOR W, VEALE DJ, MAKSYMOWYCH WP. International Spondyloarthritis Inter-observer Reliability Exercise - The INSPIRE Study: I. Assessment of Spinal Measures. Journal of Rheumatology, 2007, 34, 1733–1739.

  10. GLADMAN DD, INMAN RD, COOK RJ, MAKSYMOWYCH WP. BRAUN , DAVIS JC, LANDEWE R, MEASE J , BRANDT J, BURGOS VARGAS R, CHANDRAN V, HELLIWELL P, KAVANAUGH A, O'SHEA FD, KHAN MA, PIPITONE N, RAHMAN P, REVEILLE J D, STONE M, TAYLOR W, VEALE DJ, VANDERHEIJDE D. International Spondyloarthritis Inter-observer Reliability Exercise - The INSPIRE Study: II. Assessment of Peripheral Joints, Enthesitis and Dactylitis. Journal of Rheumatology, 2007, 34, 1740–1745.

  11. SAAD F, LIPTON A, COOK RJ, CHEN Y M, SMITH M, COLEMAN RE. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer, 2007, 110: 1860-1867.

  12. ARNOLD DA, DONAHOE L, CLARKE FJ, TKACZYK AJ, HEELS-ANSDE LLD, ZYTARUK N, COOK RJ, WEBERT KE, MC DONALD E, COOK DJ. A prospective study of bleeding incidence, site, severity and duration in critically ill patients using a novel bleeding measurement tool. Clinical Investigative Medicine, 2007, 30: E39-E102.

  13. ARNOLD DA, DENTALI F, CROWTHER MA, MEYER R, COOK RJ, SIGOUI NC, FRASER GA, LIM W AND KELTON J G. Systematic Review: efficacy and safety of Rituximab for the treatment of adults with idiopathic thrombocytopenias purpura. Annals of Internal Medicine, 2007, 146, 25-33.